2,6,13,17,23,24-Hexaoxatricyclo[17.3.1.18,12]tetracosane-5,16-dione,3-[(16S,22R)-16,22-bis[(2-O-methyl-b-D-glucopyranosyl)oxy]tricosyl]-9,10,11,20,21,22-hexahydroxy-14-[(14S,20R)-20-hydroxy-14-[(2-O-methyl-b-D-glucopyranosyl)oxy]heneicosyl]-,(1R,3R,8R,9S,10S,11R,12R,14R,19R,20S,21S,22R)- (9CI)
| Product Information | |
|---|---|
| Product Number: | AX-JH0Q |
| Product Name: | 2,6,13,17,23,24-Hexaoxatricyclo[17.3.1.18,12]tetracosane-5,16-dione,3-[(16S,22R)-16,22-bis[(2-O-methyl-b-D-glucopyranosyl)oxy]tricosyl]-9,10,11,20,21,22-hexahydroxy-14-[(14S,20R)-20-hydroxy-14-[(2-O-methyl-b-D-glucopyranosyl)oxy]heneicosyl]-,(1R,3R,8R,9S,10S,11R,12R,14R,19R,20S,21S,22R)- (9CI) |
| CAS: | 142382-45-4 |
| MW: | 0 |
| Synonyms: | BU4224V-B1; Cycloviracin B1 |
| EINECS: | |
| Density: | g/cm3 |
| Melting Point: | |
| Boiling Point: | °Cat760mmHg |
| Flash Point: | °C |
| Solubility: | |
| Risk Codes: | |
| Transport Information:: | |